Client Result
Carlyle and SK Capital Complete Acquisition of bluebird bio
2 minute read | June.12.2025

2 minute read | June.12.2025
1 minute read | March.02.2023
The proceeds from the financing will be used to advance CARGO’s autologous CD22 CAR T-cell therapy candidate, CRG-022.
September.19.2022
June.25.2021
We have advised lead investor Third Rock Ventures, as well as Lightspeed Venture Partners, on their investment in Abata Therapeutics’ Series A round.
June.04.2020